Logo image
Graphene Oxide-Based Biosensors for Liquid Biopsies in Cancer Diagnosis
期刊文章   同儕審查

Graphene Oxide-Based Biosensors for Liquid Biopsies in Cancer Diagnosis

Shiue-Luen Chen, Chong-You Chen, Jason Chia-Hsun Hsieh, Zih-Yu Yu, Sheng-Jen Cheng, Kuan Yu Hsieh, Jia-Wei Yang, Priyank Kumar, Shien-Fong Lin 和 Guan-Yu Chen
Nanomaterials (Basel, Switzerland), 卷.9(12), 頁.1725
03/12/2019
PMID: 31816919
Web of Science ID: WOS:000506675800081

摘要

Chemistry Chemistry, Multidisciplinary Materials Science Materials Science, Multidisciplinary Nanoscience & Nanotechnology Physical Sciences Physics Physics, Applied Science & Technology Science & Technology - Other Topics Technology
Liquid biopsies use blood or urine as test samples, which are able to be continuously collected in a non-invasive manner. The analysis of cancer-related biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA, and exosomes provides important information in early cancer diagnosis, tumor metastasis detection, and postoperative recurrence monitoring assist with clinical diagnosis. However, low concentrations of some tumor markers, such as CTCs, ctDNA, and microRNA, in the blood limit its applications in clinical detection and analysis. Nanomaterials based on graphene oxide have good physicochemical properties and are now widely used in biomedical detection technologies. These materials have properties including good hydrophilicity, mechanical flexibility, electrical conductivity, biocompatibility, and optical performance. Moreover, utilizing graphene oxide as a biosensor interface has effectively improved the sensitivity and specificity of biosensors for cancer detection. In this review, we discuss various cancer detection technologies regarding graphene oxide and discuss the prospects and challenges of this technology.

檔案與連結 (1)

url
https://doi.org/10.3390/nano9121725檢視
已出版(紀錄版本) 開放

相關連結

詳細資料

Logo image